Intas Pharmaceuticals Limited Spironolactone Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Spironolactone Export Records India — #4 Exporter, 1,026 Shipments, $12.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Spironolactone

India Pharmaceutical Trade Intelligence

$197.4M259 Suppliers112 CountriesHS 30049099

ExportsIndia → UNITED STATES87.2%India → NETHERLANDS6.0%

ImportsUNITED STATES → India$22.1K GERMANY → India$19.2K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Intas Pharmaceuticals Limited — Spironolactone Exporter #4 | $12.2M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Spironolactone Exporter Profile

Indian Pharmaceutical Exporter · #4 for Spironolactone · $12.2M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #4 Indian exporter of Spironolactone with $12.2M in export value and 1,026 verified shipments. Intas Pharmaceuticals Limited holds a 6.2% market share in Spironolactone exports across 9 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Spironolactone Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Spironolactone export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Spironolactone?

Country	Value	Shipments	Share
NETHERLANDS	$9.7M	546	86.9%
GUATEMALA	$1.2M	32	10.9%
CZECH REPUBLIC	$98.7K	2	0.9%
SPAIN	$89.5K	20	0.8%
POLAND

Who Are the Top Buyers of Spironolactone from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
BROCACEF NL : HUB	NETHERLANDS	$3.5M	209
TO THE ORDER	NETHERLANDS	$1.5M	109
BROCACEF NL:EU HUB	NETHERLANDS	$1.4M	57
LATIN FARMA, S.A	GUATEMALA	$1.2M	32
BROCACEF NL HUB	NETHERLANDS	$989.5K	41
BROCACEF NL:HUB	NETHERLANDS	$562.2K	26
BROCACEF NL HUB BROCACEF HEALTHCAR	NETHERLANDS	$453.5K	17
MYLAN IRELAND LTD	NETHERLANDS	$403.3K	47
BROCACEF NL : DUTCH	NETHERLANDS	$261.0K	23
MYLAN IRELAND LIMITED	NETHERLANDS	$258.0K	12

Intas Pharmaceuticals Limited supplies Spironolactone to 32 buyers globally. The largest buyer is BROCACEF NL : HUB (NETHERLANDS), followed by TO THE ORDER (NETHERLANDS) and BROCACEF NL:EU HUB (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Spironolactone Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG1	$1.1M	39
PHARMA DRUGS & MEDI Slydex Spironolactone 100mg 3x10T- MENA AS PER INVOICE	$1.1M	25
PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG10X10T(ACCORD-GERMANY AS PER INVOICE	$992.8K	47
PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG10X10T(ACCORD-GERMANY AS PER INVOICE	$809.8K	34
PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG1	$778.8K	24
PHARMA DRUGS & MEDI SPIRONOLACTONE 25MG10X10T(ACCORD-GERMANY AS PER INVOICENOS	$364.5K	30
PHARMACEUTICAL DRUGS AND MEDICINE SPIRONOLACTONE 50MG10X10T ACCORD AS PER INVOICE	$305.5K	11
PHARMA DRUGS MEDI SPIRONOLACTONE 25MG10X10T ACCORD GERMANY AS PER INVOICE	$278.2K	13
PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG10X10T(ACCORD-GERMANY AS PER INVOICENOS	$242.2K	27
PHARMA DRUG&MED:SPIRONOLACTONE 25MG10X10	$238.9K	8

Intas Pharmaceuticals Limited exports 251 distinct Spironolactone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI SPIRONOLACTONE 50MG1 with 39 shipments worth $1.1M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Spironolactone Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	AMNEAL PHARMACEUTICALS PRIVATE LIMITED	$18.6M	373	1	$50.0K
1	ZYDUS LIFESCIENCES LIMITED	$13.1M	262	3	$50.0K
4	INTAS PHARMACEUTICALS LIMITED ★	$12.2M	1,026	9	$11.9K
3	AUROBINDO PHARMA LTD	$8.3M	167	1	$50.0K
5	AUROBINDO PHARMA LIMITED	$5.0M	101	1	$50.0K

Intas Pharmaceuticals Limited ranks #4 among 259 Indian Spironolactone exporters. Average shipment value of $11.9K compared to the market average of $259.6K. The closest competitors by value are AMNEAL PHARMACEUTICALS PRIVATE LIMITED and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Spironolactone Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	870	16.5%
DELHI AIR	678	12.9%
SAHAR AIR	633	12.0%
SAHAR AIR CARGO ACC (INBOM4)	594	11.3%
MUNDRA SEA	443	8.4%
MUNDRA SEA (INMUN1)	391	7.4%
Delhi Air	164	3.1%
NHAVA SHEVA SEA (INNSA1)	132	2.5%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Spironolactone Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Spironolactone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1,048 individual customs records matching Intas Pharmaceuticals Limited exporting Spironolactone, covering 251 formulations to 9 countries via 32 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 112+ countries, 471+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Spironolactone

Spironolactone

Intas Pharmaceuticals Limited — Spironolactone Exporter Profile

Intas Pharmaceuticals Limited — Spironolactone Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Spironolactone?

Who Are the Top Buyers of Spironolactone from Intas Pharmaceuticals Limited?

What Is India's Total Spironolactone Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Spironolactone Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Spironolactone Exporters?

What Spironolactone Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Spironolactone Exporters?

Which Indian Ports Ship Spironolactone Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Spironolactone Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Spironolactone Export Data from Intas Pharmaceuticals Limited

Spironolactone Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source